Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study. - Chung HC; Saada-Bouzid E; Longo F; Yanez E; Im SA; Castanon E; Desautels DN; Graham DM; Garcia-Corbacho J; Lopez J; Dutcus C; Okpara CE; et al. (Cancer, 2024)